Neuroepidemiology

Methods in Neuroepidemiology

Free Access

Occurrence of Depression in Families with Frontotemporal Dementia: A Family History Study

Horstmann V.a · Gräsbeck A.b, c

Author affiliations

Departments of aHealth Sciences and bPsychogeriatrics and cSwedish National Institute of Health Care and Sciences, Lund University, Lund, Sweden

Corresponding Author

Vibeke Horstmann

Department of Health Sciences

Faculty of Medicine, Lund University

Box 157, SE–221 00 Lund (Sweden)

Tel. +46 46 222 1872, Fax +46 46 222 1959, E-Mail vibeke.horstmann@med.lu.se

Related Articles for ""

Neuroepidemiology 2009;33:124–130

Abstract

Background: There are clinical similarities between frontotemporal dementia (FTD) and depression. The aim is to study co-aggregation of depression in families with FTD, indicating the existence of common aetiological factors. Methods: The study included 74 index patients with FTD and their 540 first-degree relatives above the age of 15 years. Occurrence of depression was studied at 3 different levels. Results: The incidence of depression in first-degree relatives of FTD patients was not higher than that of a general population. Occurrence of depression was not higher in families where parents had FTD compared to families with parents having no indications of FTD. Individuals with FTD had not suffered from depression to a greater extent than those without FTD. Conclusions: The hypothesis of a common aetiological factor of FTD and depression was not supported.

© 2009 S. Karger AG, Basel




Related Articles:


References

  1. Brun A, Englund B, Gustafson L, Passant U, Mann DMA, Neary D, Snowden J: Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994;57:416–418.
  2. Pasquier F, Delacourte A: Non-Alzheimer degenerative dementias. Curr Opin Neurol 1998;11:417–427.
  3. Mann D, McDonagh A, Snowden JS, Neary D, Pickering-Brown SM: Molecular classification of the dementias. Lancet 2000;355:626.
  4. Poorkaj P, Grossman M, Steinbart E, Payami H, Sadovnick A, Nochlin D, Tabira T, Trojanowski JQ, Borson S, Galasko D, Reich S, Quinn B, Schellenberg G, Bird TD: Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol 2001;58:351–352.
  5. Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, de Jong D, Dooijes D, Kamphorst W, Ravid R, Niermeijer MF, Verheij F, Kremer HP, Scheltens P, van Duijn CM, Heutnik P, van Swieten JC: Frontotemporal dementia in the Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 2003;126:2016–2022.
  6. Ruddy DM, Parton MJ, Al-Chalabi A, Lewis CM, Vance C, Smith BN, Leigh PN, Powell JF, Siddique T, Meyles EP, Baas F, De Jong V, Shaw CE: Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. Am J Hum Genet 2003;73:390–396.
  7. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick SD, Rollinson S, Cannon A, Dwosh E, Neary D, Meluist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crool R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M: Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;15:2988–3001.
  8. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin J, van Duijn C, Peeters K, Sciot R, Santens P, De Pooter T, Mattheijssens M, Van den Broeck M, Cuijt I, Vennekens K, De Deyn PP, Kumar-Singh S, Van Broeckhoven C: Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006;19:666–888.
  9. Simone F, Valerio P, Labella A, Felici F: Juvenile Pick’s disease: a clinical study. Riv Neurol 1975;45:399–417.
  10. Miller BL, Cummings JL, VIllanueva-Meyer J, Boone K, Mehringer CM, Lesser IM, Mena I: Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 1991;41:1374–1382.
  11. Gregory CA, Hodges JR: Frontotemporal dementia: use of consensus criteria and prevalence of psychiatric features. Neuropsychiatr Neuropsychol Behav Neurol 1996;9:145–153.
    External Resources
  12. Damasio AR: Neuropsychology: towards a neuropathology of emotion and mood. Nature 1997;386:769–770.
  13. Risberg J, Gustafson L: Regional cerebral blood flow measurements in the clinical evaluation of demented patients. Dem Geriatr Cogn Dis 1997;8:92–97.
  14. Suzuki H, Kuroda S, Ishizu H, Fujisawa Y, Sasaki K: Depression in the early stages of Pick’s disease. Acta Med Okayama 1999;53:253–257.
  15. Larsson EM, Passant U, Sundgren PC, Englund E, Brun A, Lindgren A, Gustafson L: Magnetic resonance imaging and histopathology in frontotemporal dementia. Dement Geriatr Cogn Disord 2000;11:123–134.
  16. Landro NI, Stiles TC, Sletvold H: Neuropsychological function in nonpsychotic unipolar major depression. Neuropsychiatr Neuropsychol Behav Neurol 2001;14:233–240.
  17. Baudic S, Tzortzis C, Barba GD, Traykov L: Executive deficits in elderly patients with major unipolar depression. J Geriatr Psychiatry Neurol 2004;17:195–201.
  18. Weiland-Fiedler P, Erickson P, Waldeck T, Luckenbaugh DA, Pike D, Bonne O, Charney DS, Neumeister A: Evidence for continuing neuropsychological impairments in depression. J Affect Disord 2004;82:253–258.
  19. Hudson JI, Mangweth B, Harrison G, Pope HG Jr, De Col C, Hausman A, Gutweniger MA, Laird NM, Biebl W, Tsuang MT: Family study of affective spectrum disorder. Arch Gen Psychiatry 2003;60:170–177.
  20. Hasler G, Drevets WC, Manji HK, Charney DS: Discovering endophenotypes for major depression. Neuropsychopharmacology 2004;29:1765–1781.
  21. World Health Organisation: International Statistical Classification of Diseases and Related Health Problems, ed 10. Geneva, WHO, 1992.
  22. Gräsbeck A, Horstmann V, Englund B, Passant U, Gustafson L: Evaluation of Predictors of mortality in clinically diagnosed frontotemporal dementia. Int J Geriatr Psychiatry 2003;18:586–593.
  23. Endicott J, Andreasen N, Spitzer RL: Family History-Research Diagnostic Criteria. New York, New York State Psychiatric Institute, 1975.
  24. Andreasen N, Endicott J, Spitzer L, Winokur G: The family history method using diagnostic criteria: reliability and validity. Arch Gen Psychiatr 1977;34:1229–1235.
  25. Brun A, Gustafson L: The Lund Longitudinal Dementia Study: a 25-year perspective on neuropathology, differential diagnosis and treatment; in Corain B, Nicolini M, Winblad B, Wisniewski H, Zatta P (eds): Alzheimer’s Disease: Advance in Clinical and Basic Research. New York, John Wiley & Sons, 1993, pp 4–18.
  26. Barber R, Snowden JS, Craufurd D: Frontotemporal dementia and Alzheimer’s disease: retrospective differentiation using information from informants. J Neurol Neurosurg Psychiatry 1995;59:61–70.
  27. Gräsbeck A, Horstmann V, Nilsson K, Sjöbeck M, Sjöström H, Gustafson L: Dementia in first-degree relatives of patients with frontotemporal dementia (FTD) – a family history study. Dement Geriatr Cogn Disord 2005;19:145–153.
  28. Hagnell O, Lanke J, Öjesjö L, Rorsman B: The Incidence of Mental Illness over a Quarter of a Century. Stockholm, Almqvist & Wicksell, 1990.
  29. Kendler KS, Davis CG, Kessler RC: The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study. Br J Psychiatry 1997;170:541–548.
  30. Gustafson L: Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987;6:209–223.
  31. Gregory CA: Frontal variant of frontotemporal dementia: a cross-sectional and longitudinal study of neuropsychiatric features. Psychol Med1999;29:1205–1217.
  32. Elderkin-Thompson V, Boone KB, Hwang S, Kumar A: Neurocognitive profiles in elderly patients with frontotemporal degeneration or major depressive disorder. J Int Neuropsychol Soc 2004;10:753–771.
  33. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546–1554.
  34. Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, Coryell W, Warshaw M, Turvey C, Maser JD, Endicott J: Multiple recurrences of major depressive disorder. Am J Psychiatry 2000;157:229–233.
  35. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ: Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol 2001;58:1803–1809.
  36. Gräsbeck A, Englund B, Horstmann V, Passant U, Gustafson L: Predictors of mortality in clinically diagnosed frontotemporal dementia. Int J Geriatr Psychiatry 2003;8:594–601.
    External Resources
  37. Kessing LV: Course of illness in depressive and bipolar disorders. Br J Psychiatry 2004;185:372–377.
  38. Snowden JS, Neary D, Mann DM: Autopsy proven sporadic frontotemporal dementia due to microvacuolar-type histology, with onset at 21 years of age. J Neurol Neurosurg Psychiatry 2004;75:1337–1339.
  39. Faraone SV, Tsuang MT: Methods in psychiatric genetics; in Tsuang MT, Tohen M, Zahner GEP (eds): Textbook in Psychiatric Epidemiology. New York, John Wiley & Sons, 1995, pp 81–134.
  40. Andreasen N, Rice J, Endicott J, Reich T, Coryell W: The family history approach to diagnosis: how useful is it? Arch Gen Psychiatr 1986;43:421–429.
  41. Rorsman B, Gräsbeck A, Hagnell O, Lanke J, Öhman R, Öjesjö L, Otterbeck L: A prospective study of first incidence depression. The Lundby Study. Br J Psychiatry 1990;156:336–342.

Article / Publication Details

First-Page Preview
Abstract of Methods in Neuroepidemiology

Received: February 01, 2009
Accepted: May 03, 2009
Published online: June 26, 2009
Issue release date: August 2009

Number of Print Pages: 7
Number of Figures: 2
Number of Tables: 4

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: https://www.karger.com/NED


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP